Cyclerion Therapeutics (CYCN) Cash & Current Investments (2019 - 2025)
Historic Cash & Current Investments for Cyclerion Therapeutics (CYCN) over the last 7 years, with Q3 2025 value amounting to $4.6 million.
- Cyclerion Therapeutics' Cash & Current Investments rose 5905.29% to $4.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.6 million, marking a year-over-year increase of 5905.29%. This contributed to the annual value of $3.2 million for FY2024, which is 5731.08% down from last year.
- According to the latest figures from Q3 2025, Cyclerion Therapeutics' Cash & Current Investments is $4.6 million, which was up 5905.29% from $3.0 million recorded in Q2 2025.
- Cyclerion Therapeutics' 5-year Cash & Current Investments high stood at $70.4 million for Q2 2021, and its period low was $2.9 million during Q3 2024.
- Moreover, its 5-year median value for Cash & Current Investments was $7.6 million (2023), whereas its average is $20.6 million.
- Its Cash & Current Investments has fluctuated over the past 5 years, first crashed by 8256.78% in 2023, then skyrocketed by 5905.29% in 2025.
- Quarter analysis of 5 years shows Cyclerion Therapeutics' Cash & Current Investments stood at $54.0 million in 2021, then plummeted by 75.2% to $13.4 million in 2022, then plummeted by 43.42% to $7.6 million in 2023, then tumbled by 57.31% to $3.2 million in 2024, then skyrocketed by 41.34% to $4.6 million in 2025.
- Its Cash & Current Investments stands at $4.6 million for Q3 2025, versus $3.0 million for Q2 2025 and $3.6 million for Q1 2025.